Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alejandro Castellvi

Neurological Surgery Pittsburgh, PA Medical Doctor

NPI 1356627350 CMS profile 373536

320 E North Ave Ste 208, Ste 140, Pittsburgh, PA 15212

Open in the dashboard

General payments

$60,550

268 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alejandro Castellvi of Pittsburgh, PA is reported in the CMS Open Payments database as having received $60,550 across 268 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,499 55
2024 General $20,215 65
2023 General $15,627 41
2022 General $3,492 17
2021 General $1,127 29
2020 General $752 24
2019 General $3,838 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alejandro Castellvi
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Alejandro Castellvi were reported at $15,499. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Alejandro Castellvi Neurological Surgery median Middle half National median
2019 $3,838 $582 $138–$3,006 $163
2020 $752 $294 $76–$2,174 $114
2021 $1,127 $387 $105–$2,432 $132
2022 $3,492 $542 $139–$2,989 $149
2023 $15,627 $534 $145–$2,697 $160
2024 $20,215 $574 $155–$3,046 $164
2025 $15,499 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Life Spine, Inc. $20,736 26 payments
  2. Medtronic, Inc. $16,726 64 payments
  3. Elevation Spine, Inc. $6,085 13 payments
  4. Stryker Corporation $5,503 63 payments
  5. Alphatec Spine, Inc $2,365 6 payments
  6. Choice Spine, LLC $2,197 2 payments
  7. Medtronic USA, Inc. $1,765 16 payments
  8. Spinal Elements, Inc. $876 9 payments
  9. Osseus Fusion Systems, LLC $809 2 payments
  10. The Institute of Musculoskeletal Science and Education $500 1 payment
  11. Other $2,989 66 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $32,843 21 payments
  2. Travel and Lodging $19,044 64 payments
  3. Food and Beverage $8,663 183 payments
Products named General payments · program years 2019–2025
  1. ProLift Lateral Helo $17,882 14 payments
  2. PRO-LINK STAND-ALONE CERVICAL SPACER SYSTEM $8,624 3 payments
  3. PRO-LINK TI $8,174 6 payments
  4. TruLift Lateral $7,252 1 payment
  5. MAZOR X SYSTEM $3,251 37 payments
  6. ProLift Lateral $2,532 12 payments
  7. ProLift Lateral Fixated $2,517 11 payments
  8. CENTRIC - T RETRACTOR $2,382 11 payments
  9. SENTRY LATERAL PLATING SYSTEM $2,369 10 payments
  10. Other - Miscellaneous $2,326 4 payments
  11. Other $26,639 187 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

24

Median for Neurosurgery: 83

Drug cost

$192

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 24 $192

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 65 billing codes

Paid by Medicare

$159,276

Medicare's payments for the services billed

Medicare patients

267

Average age 73

Services billed

703

140 women, 127 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 46%
Depression 37%
Diabetes 36%
Chronic kidney disease 32%
COPD 23%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $23
$23 — —
AJOVY
  • Teva Pharmaceuticals USA, Inc. $17
$17 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

268 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record